Format

Send to

Choose Destination
Gynecol Oncol. 2009 Oct;115(1):132-134. doi: 10.1016/j.ygyno.2009.06.006.

American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Author information

1
American Society of Clinical Oncology, Cancer Policy and Clinical Affairs Department, 2318 Mill Road, Suite 800, Alexandria, VA 22314, USA.

Erratum in

  • Gynecol Oncol. 2010 Mar;116(3):592. Visvanathan, Kala [added]; Lippman, Scott M [added]; Hurley, Patricia [added].
PMID:
19716939
PMCID:
PMC4119170
DOI:
10.1016/j.ygyno.2009.06.006
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center